Health Care

As companies are preparing to grapple with new regulations under the Affordable Care Act, a business-backed bill in California is aiming to allow small businesses to keep non-compliant plans for an extra year.

Keep calm and take notes.

The first half of the year is off to the best start since 2000 for U.S. IPOs, according to Dealogic.

The second quarter of this year saw the most U.S. venture funding since the dotcom boom days, according to data from Thomson Reuters and the National Venture Capital Association.

Trupanion a pet insurance company, rose 14% in its trading debut Friday. After pricing at $10 per share, the company raised $71 million in the offering.

It is important to recognize that some small business owners have an uphill battle to meet the requirements of the ACA. But it’s not all doom and gloom. Here’s what you need to know.

Generic-drug maker accuses warehouse club of improperly forcing it to pay kickbacks so its pharmacies would stock its drug atorvastatin.

Florida Gov. Rick Scott was served a venti verbal latte at a local Gainsville Starbucks on Tuesday after a woman publicly shamed the Republican governor for having rejected plans to expand state spending initiatives such as the Medicaid program.

U.S. drugmaker Pfizer and Ireland-based Allergan formally announced the scrapping of their $160 billion merger on Wednesday, in a big win for President Barack Obama who has been pushing to curb tax-slashing "inversion" deals.

Walgreens Boots Alliance reported a better-than-expected quarterly profit, helped by cost cutting and synergies from taking full control of European pharmacy chain Alliance Boots.

A look at the best and worst ETFs during the 1Q.

By 2025, it is estimated that automation will displace 22.7 million jobs according to Forrester Research.

As if taxes weren’t complicated enough, ObamaCare adds a new layer of confusion to the filing process. Here is some help.

Valeant Pharmaceuticals said it had asked its lenders to agree to waive a condition of its credit facility that would put it in breach of covenants if the company did not file its annual report by April 29, as planned.

ConAgra, Kellogg’s, General Mills, Mars have all recently announced plans to label GMOs after Vermont’s mandate.

Turing Pharmaceuticals Chief Commercial Officer Nancy Retzlaff looks back on the company’s decision to raise the price of the drug Daraprim by 5,000% and the ensuing fallout.

Here’s how consumers can navigate the ObamaCare exchanges to find the best plan that meets their health and financial needs.

As a key element of the ObamaCare health-care reform effort takes effect, America remains sharply divided on its merits. 

As a key element of the ObamaCare health-care reform effort takes effect, America remains sharply divided on its merits.